期刊文献+

荧光原位杂交(FISH)技术在尿路上皮肿瘤诊断中的应用研究 被引量:2

Study on diagnosis of urothelial carcinoma by fluorescence in situ hybridization(FISH)
下载PDF
导出
摘要 目的应用荧光原位杂交(FISH)技术探索中国人群中3、7和17号染色体及9p21位点异常与尿路上皮肿瘤发生、发展的关系,评估其用于中国人群尿路上皮肿瘤诊断的可行性及临床应用前景。方法收集102例以血尿症状就诊,证实为尿路上皮肿瘤患者的新鲜晨尿,连续留取3d,将标本分别以FISH技术和尿脱落细胞学方法加以检测。收集20名正常成人新鲜晨尿,同法操作并计算正常成人对照组参考值。收集临床资料,明确肿瘤临床分期和病理分级。以正常成人对照组参考值判定患者FISH结果,比较其与尿脱落细胞学检测方法诊断的阳性检出率。统计分析3、7和17号染色体及9p21位点畸变率与性别、年龄、肿瘤初发、复发、单发、多发、临床分期及病理分级的相关性。结果①各染色体及区带均呈现较高的畸变发生率。多体畸变发生率由高到低为98.0%(7号)、97.1%(3号)、96.1%(17号)和83.3%(9p21位点);单体畸变发生率由高到低为95.1%(9p21位点)、68.6%(17号)、67.4%(7号)和66.7%(3号);缺失畸变则仅见于9p21位点(31.4%)。②尿脱落细胞学检查的肿瘤阳性检出率为64.7%,FISH则为98.0%,两者差异有统计学意义(χ2=30.25,P<0.01)。③各染色体畸变与患者的性别、年龄、肿瘤初发、复发、单发、多发及肿瘤临床分期均未见显著相关性。④3号染色体单体畸变与肿瘤病理分级间呈正相关(r=0.198,P=0.046),其余染色体不同类型的畸变情况均未显示出与不同病理分级间存在显著相关性。⑤3、7及17号染色体主要以多体畸变为主,而9p21位点主要以单体畸变为主(χ2=166.426,P<0.001),尚无证据表明各染色体与缺失畸变间的倍性关系。结论①FISH技术是通过尿液样本检测尿路上皮肿瘤染色体畸变的有效方法,可作为早期诊断尿路上皮肿瘤的重要辅助手段。②尿路上皮肿瘤在3、7和17号染色体及9p21位点同时存在多种畸变类型,且各畸变类型均具有较高的畸变率。③3号染色体的缺失或单体畸变可能对尿路上皮肿瘤的进展具有一定预测意义。 Objective To study the relations between aberrations of chromosome 3,7,17,9p21 and urothelial carcinoma,especially the bladder transitional cell carcinoma(BTCC)by the fluorescence in situ hybridization(FISH).To evaluate the feasibility and the perspective of clinical applications of FISH in the diagnosis of urothelial carcinoma in Chinese group.Methods We collected the morning urine specimens of 102 patients who were diagnosed as urothelial carcinoma by biopsies or postoperative pathologic examinations,and then made tests on these specimens by FISH and uroexfoliative cytology respectively.The control group was set by detecting the morning urine specimens of 20 healthy persons using the technique of FISH in order to confirm the normal threshold value.The patients' positive results of FISH were defined according to the criteria made on the basis of the normal threshold value.Finally,we compared the positive detective rates between FISH and uroexfoliative cytology and analyzed whether the rates of abnormalities in chromosome 3,7,17,9p21 have significant associations with sex,ages,recurrence,multi-foci,clinical and pathologic tumor stages statistically.Results ①The polysomic aberration rates were 98.0%(7),97.1%(3),96.1%(17),83.3%(9p21);The monosomic aberration rates were 95.1%(9p21),68.6%(17),67.4%(7),66.7%(3);②The positive detective rates of FISH was 98.0%,while the uroexfoliative cytology was 64.7%.There was significant difference between these two techniques(χ2=30.25,P〈0.01);③There were no correlation between abnormalities of chromosomes and sex,ages,recurrence,multi-foci and clinical stages significantly;④The polysomic aberration rates of chromosome 3 were associated with pathologic stage significantly(r=0.198,P=0.046);⑤The main aberrative pattern of chromosome 3,7,17 was polysomy,chromosome 9p21 was monosomy(χ^2=166.426,P〈0.001).Conclusions ①FISH is an effective method to detect chromosomal aberrations of urothelial carcinoma through the urine samples,which could also be ued as a good auxiliary technique in the diagnosis of urothelial carcinoma;②There exist both polysomic and monosomic aberrations in chromosome 3,7,17,9p21 and the high aberration frequency could be detected in each type of chromosomal abnormality;③The deletion and monosomic aberrations of chromosome 3 could be a indicative sign of tumor's progression.
出处 《现代泌尿生殖肿瘤杂志》 2010年第4期219-223,共5页 Journal of Contemporary Urologic and Reproductive Oncology
关键词 原位杂交 荧光 尿路上皮肿瘤 染色体畸变 诊断 In situ hybridization fluorescence Urothelial carcinoma Chromosome aberrations Diagnosis
  • 相关文献

参考文献19

  • 1Parkin MD, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin, 2005, 55(2) :74-108.
  • 2Inoue T, Nasu Y,Tsushima T, et al. Chromosomal numerieal aberrations of exfoliated cells in the urine detected by fluorescense in situ hybridization: elinical implication for the detection of bladder cancer[J]. Urol Res, 2000, 28(1):57-61.
  • 3Schmidbauer J, Witjes F, Schmeller N, et al. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy[J]. J Urol,2004, 171(1) : 135-138.
  • 4Jones JS. DNA-based molecular cytology for bladder cancer surveillance[J]. Urology, 2006, 67(3 Supple 1):35-45.
  • 5Lu ML,Wikman F,Orntoft TF,et al. Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods [J]. Clin Cancer Res, 2002, 8(1):171-179.
  • 6Qin SL, Chen XJ, Xu X, et al. Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization[J]. Cancer Lett, 2006, 238(2):230-239.
  • 7Vanni R,Scarpa RM, Nieddu M, et al. Cytogenetic investigation on 30 bladder carcinornas[J]. Cancer Genet Cytogenet, 1988, 30(1) :35-42.
  • 8sandberg AA,Berger C. Review of chromosome studies in urological tumors. Cytogenetics and molecular genetics of bladder cancer[J]. J Urol, 1994, 151(3) :545-560.
  • 9Kruger S, Mess F, Bohle A, et al. Numerical aberrations of chromosome17 and 9p21 locus are independent predictors of number recurrence in non-invase transitional cell carcinoma of urinary bladder[J].Int J Onco, 2003,123 (1) :41-78.
  • 10Waldman FM,Carroll PR,Kerschmana R;et al. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer[J]. Cancer Res, 1991, 51 (14):3807-3813.

二级参考文献11

  • 1Ohta M, Inoue H, Cotticelli MG, et al. The FHIT gene, spanning carcinoma associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996, 84: 587-597.
  • 2Bronner CE, Baker SM, Morrison PT, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994, 368: 258-261.
  • 3Clifford SC, Prowse AH, Affara NA. Inactivation of the von Hippel-lindau(VHL) tumour suppressor gene and allellic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumorigenesis. Genes Chromosomes Cancer. 1998, 22: 200-209.
  • 4Mostofi FK, Davis CJ, Sesterhenn IA, et al. Histological typing of urinary bladder tumors. Berlin: Spring, 1999: 9-15.
  • 5Zhang J, Fan Z, Gao Y, et al. Detecting bladder cancer in the Chinese by microsatellite analysis: ethnic and etiological considerations. J Natl Cancer Inst, 2001, 93: 45-50.
  • 6Inoue H, Ishii H, Alder H, et al. Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion. Proc Natl Acad Sci USA, 1997, 94: 14584-14589.
  • 7Wada T, Louhelainen J, Hemminki K, et al. The prevalence of loss of heterozygosity in chromosome 3, including FHIT, in bladder cancer, using the fluorescent multiplex polymerase chain reaction. BJU International , 2001, 87: 876-881.
  • 8Acopetta BJ, Soong R, House AK, et al. Gastric carcinomas with microsatellite instability: clinical features and mutations to the TGF-beta type II receptor, IGFII receptor, and BAX genes. J Pathol, 1999, 187: 428-432.
  • 9Atif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science, 1993, 260: 1317-1320.
  • 10Li M, Zhang ZF, Reuter VE, et al. Chromosome 3 allelic losses and microsatellite alterantions in transitional cell carcinoma of the urinary bladder. Am J Pathol 1996, 149: 229-235.

共引文献7

同被引文献20

  • 1孔垂泽,刘奔,李振华,杨绍波,孙志熙.预防肾盂输尿管癌术后再发膀胱癌的手术方法研究[J].中华泌尿外科杂志,2006,27(4):250-252. 被引量:22
  • 2罗俊航,陈炜,陈凌武,孙祥宙,王道虎,戴宇平.Hem-o-lok结扎锁在后腹腔镜肾切除术肾蒂血管处理中的应用[J].腹腔镜外科杂志,2007,12(3):183-184. 被引量:11
  • 3Matsui Y, Utsunomiya N, Ichioka K, et al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract[ J]. U- rology, 2005,65 : 279.
  • 4Clayman RV, Kavoussi LR, Figenshau RS, et al. Laparosco- pic nephroureterectomy :initial clinical case report[ J]. Lap- aroendosc Surg, 1991,1:343.
  • 5Kume H,Teramoto S,Tomita K,et al. Bladder recurrence of upper urinary tract cancer after laparoscopic surgery [ J ]. J Surg Onco1,2006,93 (4) :318.
  • 6Hattori R, Yoshino Y, Gotoh M, et al. Laparoscopic nephro- ureterectomy for transitional cell carcinoma of renal pelvis and ureter: Nagoya experience [ J). Urology, 2006,67 ( 4 ) : 701.
  • 7Matin SF. Radical laparoscopic nephroureterectomy for up- per urinary tract transitional cell carcinoma:current status [J ]. BJU Int,2005,95(2) :68.
  • 8Raman JD, Palese MA, Ng CK, et al. Hand-assisted laparo- scopic nephroureterectomy for upper urinary tract transition- al cell carcinoma[ J ]. JSLS,2006,10 (4) :432.
  • 9Vardi IY, Stern JA, Gonzalez CM, et al. Novel technique for management of distal ureter and en block resection of blad- der cuff during hand-assisted laparoscopic nepphroureterec- tomy [ J ]. Urology,2006,67 : 89.
  • 10Chen GL, Bagley DH. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal con- tralateral kidneys [ J ]. Urology,2000,164 (4) : 1173.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部